Zusammenfassung
In fortgeschrittenen Tumorstadien leid en 70–90% der Patienten unter behandlungsbedürftigen Schmerzzuständen. Schmerzen sind das häufigste Symptom maligner Erkrankungen. Deshalb ist eine frühzeitige interdisziplinäre Diagnostik und Therapie von Schmerzen bei Tumorpat ienten notwendig. Neben einer Kausaltherapie muss parallel mit einer symptomatischen medikamentösen Schmerzbehandlung begonnen werden. Nach wie vor existieren Vorurteile und Informationsdefizite über die Wirkung von Morphin.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Janig H, Pipam W, Lastin S, Sittl R, Bernatzky G, Likar R (2005) Pain experience and pain therapy of tumor patients in the view of general practitioners. Schmerz 19(2): 97–108
Valeberg BT, Rustøen T, Bjordal K, Hanestad BR, Paul S, Miaskowski C (2008) Self-reported prevalence, etiology, and characteristics of pain in oncology outpatients. Eur J Pain 12(5):582–90
Stute P, Soukup J, Menzel M, Sabatowski R, Grond S (2006) Analysis and treatment of different types of neuropathic cancer pain. J Pain Symptom Manage 26(6): 1123–31
Felleiter P, Gustorff B, Lierz P, Hornykewycz S, Kress HG (2005) Use of the World Health Organisation guidelines on cancer pain relief before referral to a specialized pain service. Schmerz, 19(4):265–71
Maj S, Centkowski P (2004) A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland. Med Sci Monit 10(9):PI93–5
Munir MA, Enany N, Zhang JM (2007) Nonopioid analgesics. Med Clin North Am 91(1):97–111
Mercadante S, Fulfaro F, Casuccio A (2002) A randomised controlled study on the use of antiinframmatory drugs in patients with cancer pain on morphine therapy: effects on doseescalation and a pharmacoeconomic analysis. Eur J Cancer 38(10):1358–63
Mercadante S, Radbruch L, Caraceni A, Cherny N, Kaasa S, Nauck F, Ripamonti C, De Conno F, Steering Committee of the European Association for Palliative Care (EAPC) Research Network (2002) Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer 94(3):832–9
Sittl R, Nuijten M, Nautrup BP (2006) Patterns of dosage changes with transdermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: a retrospective data analysis in Germany. Clin Ther 28(8):1144–54
Platzer M, Likar R, Stein C, Beubler E, Sittl R (2005) Topical application of morphine gel in inflammatory mucosal and cutaneous lesions. Schmerz 19(4):296–301
Cleary JF (2000) Cancer pain management. Cancer Control 7(2):120–31
Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH (2005) Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118(3):289–305
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag/Wien
About this chapter
Cite this chapter
Likar, R., Bernatzky, G. (2009). Medikamentöse Tumorschmerztherapie. In: Likar, R., Bernatzky, G., Märkert, D., Ilias, W. (eds) Schmerztherapie in der Pflege. Springer, Vienna. https://doi.org/10.1007/978-3-211-72328-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-211-72328-9_12
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-72086-8
Online ISBN: 978-3-211-72328-9
eBook Packages: Medicine (German Language)